Unit IX – API
Pashamylaram, Hyderabad
- Blocks
- 6
- Area
- 98,000 sq.ft
Aurobindo Pharma Limited
Vertically integrated global API manufacturer with USFDA, EU GMP and PMDA compliant facilities supplying regulated markets across 6 continents.
APINEXA verifies every manufacturer for compliance, regulatory documentation availability, and active export capability before listing.
Aurobindo Pharma is one of the largest vertically integrated pharmaceutical companies in India with a strong global footprint across regulated markets. The company manufactures Active Pharmaceutical Ingredients (APIs), generic finished dosage forms, and biosimilars across multiple therapeutic categories. With a presence in over 150 countries, Aurobindo operates 25+ manufacturing facilities — many of which are USFDA, EU GMP, WHO GMP and PMDA inspected — supporting commercial-scale supply for global generic, branded and innovator partners.
Production capacity, technology platforms, and clean-room infrastructure verified at the manufacturer source.
A curated view of marquee molecules supplied by this manufacturer. Filter by therapeutic area to narrow results.
CAS 134523-03-8
CAS 1115-70-4
CAS 147098-20-2
CAS 191732-72-6
CAS 120202-66-6
CAS 654671-77-9
Authority-by-authority regulatory standing for major regulated and semi-regulated pharmaceutical markets.
| Region | Authority | Status |
|---|---|---|
United States | USFDA | Approved |
Europe | EU GMP / EDQM | Approved |
Japan | PMDA | Approved |
Brazil | ANVISA | Approved |
Australia | TGA | Approved |
South Korea | MFDS | Filed |
Mexico | COFEPRIS | Approved |
Russia | Roszdravnadzor | Approved |
Live supply footprint grouped by market regulatory class — Regulated, Semi-Regulated, and Emerging.
No countries in this category.
Active commercial exports across regulated markets, with documentation packs available per region.
Each facility is verified for clean-room class, production blocks, and built-up area.
Pashamylaram, Hyderabad
Jadcherla, Telangana
Bachupally, Hyderabad
MOQ flexibility, lead times, packaging formats, and supply-flexibility signals to support procurement teams.
Secure document access. Restricted documents require an NDA submitted through the RFQ form.
Send a structured inquiry routed through APINEXA's coordination team — confidential, compliance-pre-checked, audit-grade. Typical response in 6 hours.